Ligand · SL1

SL1 · N-((1S)-4-{[amino(imino)methyl]amino}-1-formylbutyl)-2-{(3R)-3-[(benzylsulfonyl)amino]-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl}acetamide

SL1, N-((1S)-4-{[amino(imino)methyl]amino}-1-formylbutyl)-2-{(3R)-3-[(benzylsulfonyl)amino]-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl}acetamide (C30 H33 N7 O5 S, 603.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2…

Component: SL1
Formula: C30 H33 N7 O5 S
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

SL1 in 2 structures; the first of them:

1W12 · Urokinase type plasminogen activator · SL1 U1245 · binds HIS57, ASP97, THR97A, LEU97B, ALA98, HIS99, ASP189, SER190 and 13 more
1W12 · Urokinase type plasminogen activator · SL1 U1245 · binds HIS57, ASP97, THR97A, LEU97B, ALA98, HIS99, ASP189, SER190 and 13 more

Residues it binds most

GLY 2, SER 2, ALA 2, ASP 2, CYS 2, HIS 2, ARG 2, GLN 2, LEU 2, THR 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.